Pharma Now - Empowering Pharma Leadership’s Post

CPHI survey ranks India as fastest-growing region

When it comes to regulatory intelligence and strategy in Mexico and LATAM, Udelá is your best ally. Connect with us at CPHI Milan and discover how we can help you successfully navigate regulatory challenges with confidence. 💙🤝🏽

As one of my big projects for this year - Selectchemie’s presence and marketing activities at CPHI - comes to a close - I have had some time to reflect on the wild ride it has been - from the early planning stages to the execution. Anybody that has worked in events knows that no amount of organising and planning for eventualities and different scenarios can truly prepare you for the things that often end up happening once « showtime » comes around. For me these were the keys in managing unforeseen challenges that needed quick solutions: 🔑 Having a solid plan but remaining flexible. Things are not going to work out exactly according to the script but it helps immensely to have a compass that helps you find north and make quick decisions that are directionally right. 🔑 In moments of calm - thinking one step ahead to try to anticipate problems that may arise so you buy yourself time to craft « Plan B » or « Plan C » 🔑 Thinking outside the box and being open to creative solutions that solve the problem pragmatically. 🔑 Having a team that is willing to put in the hours and get stuck in while maintaining a positive attitude. 🔑 Having a laugh when things do not go according to plan - shaking it off quickly - moving on and quickly going back into problem solving mode. Grateful for the Selectchemie team that made this year’s CPHI a success! Looking forward to getting started on preparations for Frankfurt 2025 soon!🔜 But for now - a couple of deep breaths 🧘♀️ #events #eventmarketing #keepcalm -- 💬 Comment with your experience and thoughts! I‘m curious! 👇A video of our time at CPHI - enjoy 🎬

Pharma professionals from around the world have been traveling to connect, engage and thrive here at CPHI & PMEC India - for three days of powerful collaboration. Many of the CPHI team were also traveling today and yesterday to attend South Asia's largest pharma event: here is a short video of their journeys! #Pharma #CPHIPMECIndia #HeartOfPharma How was your journey and did you take any photos on the way? Share in the comments below!

Attending CPHI China is a strategic imperative for pharmaceutical companies involved in API supply and manufacturing. This premier event offers unparalleled networking opportunities, allowing companies to connect with key industry players, potential clients, and strategic partners from around the globe. Additionally, CPHI China showcases the latest advancements in pharmaceutical technology and API manufacturing, providing valuable insights into industry trends and innovations. By participating in this event, companies can stay updated on market developments, discover new products, and integrate cutting-edge solutions into their operations, enhancing efficiency and competitiveness. Moreover, CPHI China serves as a platform to strengthen supplier relationships and boost brand visibility. Face-to-face interactions with existing and potential suppliers facilitate better deals and ensure supply chain reliability. Exhibiting at the event also allows companies to showcase their products and innovations to a global audience, attracting new customers and investors. To maximize these benefits, our specialized travel packages offer convenient travel arrangements, comfortable accommodations, and assistance with event registration, ensuring a seamless and productive experience. Investing in a travel package with us enables pharmaceutical professionals to focus on making the most of CPHI China, driving business growth and securing a competitive edge in the industry. #PharmaIndustry #PharmaInnovation #PharmaLeadership #DrugDiscovery #HealthcareSolutions #PharmaTech #Biopharma #MedicalResearch #PharmaManufacturing #PharmaLife #HealthcareAdvancements #PharmaMarketing #ClinicalTrials #PharmaNews #BioTech #CPHIChina #PharmaNetworking #CPHIBusiness #PharmaInnovation #CPHIExpo #ChinaPharmaMarket #CPHIConnections #PharmaIndustry #CPHIShanghai #PharmaCollaboration #CPHI2024 #PharmaLeaders #CPHIEssentials #PharmaEvents #CPHITradeShow Ajaz Raien Khan Imran

The pharmaceutical industry's future is shaped by the connections we build and the ideas we exchange. That’s why we’re thrilled to have one of our team members on the ground at CPHI Middle East this year. Are you attending? Let’s meet and talk about how innovation in marketing can help shape the future of the pharmaceutical and healthcare industries. #CPHIMiddleEast #Innovation #Collaboration #HealthcareMarketing

NEW INTERVIEW! CPHI Middle East: THE OPPORTUNITIES AHEAD FOR ADVANCED MANUFACTURING IN MIDDLE EAST AND PARTNERING IN AFRICA At last month’s CPHI Milan – the world’s largest pharma event with 60,000 attendees – one of the key growth markets for the next decade was explored in depth. With the inaugural CPHI Middle East set to launch in Riyadh from December 10th-12th, we spoke with Pushpa Vijayaraghavan Healthcare Practice Lead for Sathguru Management Consultants. Pushpa, who spoke on a panel at CPHI Milan, will also be present at next month’s CPHI Middle East panel on Evolving continental and regional opportunities in Africa. We discussed opportunities in Saudi Arabia to help the government meet its ambitious goals of building an advanced manufacturing and biomanufacturing hub in the region, how global innovators and generic majors can contribute to the region, and how the region can serve as a gateway platform for delivering vital medicines across Africa. CPHI Middle East 2024 will welcome over 30,000 visitors and 400 exhibitors, making it the region’s largest pharma event. As Saudi Arabia’s $12.1 billion pharma market undergoes rapid transformation under Vision 2030, the event will bring new opportunities for private investment and partnerships. With over 81% of generic drugs and 94% of medical devices currently imported, Saudi Arabia offers significant potential for companies to localize production and support its expanding healthcare sector. Full interview available here: https://lnkd.in/g5eydpEn

Why Saudi Arabia is the Next Hub for Biotech and Pharma Companies: Insights from CPHI Riyadh Attending the recent CPHI Conference in Riyadh highlighted the immense potential Saudi Arabia holds for the biotech and pharmaceutical industries. As the Kingdom continues its transformative journey under Vision 2030, it’s clear that the region is positioning itself as a global leader in healthcare innovation and pharmaceutical excellence. Here’s why Saudi Arabia is becoming an increasingly attractive destination for biotech and pharma companies: 1. Strategic Vision and Government Support Vision 2030 emphasizes the development of a robust healthcare sector. With substantial government investments and initiatives aimed at fostering research and development, Saudi Arabia is creating an ecosystem that encourages innovation and collaboration in biotech and pharmaceuticals. 2. State-of-the-Art Infrastructure From advanced manufacturing facilities to research hubs, the Kingdom has invested in building world-class infrastructure to support the life sciences sector. This infrastructure not only enhances local production but also facilitates global partnerships. 3. Growing Market Demand With a rapidly expanding population and an increasing focus on chronic disease management, the demand for innovative therapeutics is at an all-time high. Saudi Arabia provides a unique opportunity for companies to tap into a high-growth market. 4. Regulatory Advancements The regulatory framework in Saudi Arabia has evolved to streamline approvals, making it easier for companies to introduce innovative products while ensuring patient safety. 5. Global Partnerships Events like CPHI Riyadh underscore the Kingdom’s commitment to fostering international collaborations. These platforms allow stakeholders to exchange knowledge, explore opportunities, and drive advancements in healthcare. Saudi Arabia is not just an emerging market; it’s a strategic partner for companies looking to innovate and grow in the biotech and pharma space. The discussions and insights from CPHI Riyadh reinforced the Kingdom’s immense potential. What are your thoughts on Saudi Arabia’s potential as a global leader in biotech and pharma? Feel free to share your insights or reach out if you’d like to discuss more. #CPHI2024 #Vision2030 #Biotech #Pharma #SaudiArabia #Innovation #HealthcareTransformation

Market Access Today is thrilled to announce its role as the official partner of the upcoming MENAHTA Forum 2024, a leading conference dedicated to Health Technology Assessment (HTA) excellence in the Middle East and North Africa (MENA) region. Scheduled for June 5th, 2024, at the prestigious Le Méridien Dubai Hotel + Conference Centre, this event promises to be a pivotal gathering for regulatory, market access, pricing, and commercial experts in the life sciences sector. The MENAHTA Forum 2024 is designed to educate and empower pharmaceutical industry decision-makers and distributors on the successful implementation of HTA in the MENA region. Attendees will gain critical insights into how HTA is shaping the future of healthcare and how it can drive commercial success during this transformative period. Key agenda highlights include discussions on the value approaches for innovative pharmaceutical products, HTA advancements and regional insights from Jordan, cost-effectiveness thresholds in the UAE, the importance of evidence generation for HTAs, and strategies for implementing value-based technology assessments. As the official partner, Market Access Today is proud to support this essential forum, which aligns with our commitment to fostering innovation and excellence in healthcare. We invite pharmaceutical professionals, distributors, and wholesalers to join us for this enlightening event to enhance their knowledge and strategies for market access in the MENA region. For more information: https://lnkd.in/drwTFYD5 Special Offer: Attendees can enjoy a 15% discount on registration by using the code "ZAG15". Register now to secure your spot at the MENAHTA Forum 2024, and prepare to engage in insightful discussions that will undoubtedly influence the future of healthcare in our region. We look forward to welcoming you and contributing to a day of significant learning and networking opportunities. #menahta #marketaccess #reimbursement #pricing #hta #heor #healtheconomics #pharmacoeconomics #health #pharmaceuticals #medicaldevices #HTA #MENA

We are heading to #CPHIMilan this October! Come say hello at #Booth24A1, #Hall24, #ZoneIntegratedPharma, to experience the unmatched strengths of Hetero's global marketing arms. Discover the unified power of Hetero — Camber Pharmaceuticals Inc, Amarox Pharma GmbH, SEVEN PHARMA - LATAM, and HETERO HEALTHCARE LIMITED — as we come together under our transformative theme: #ForEveryoneEverywhere Driven by a singular purpose: to #inspire human #belief in a #healthierworld, we cater to your #API, #FDF, #CDMO, and #Biosimilars needs. Let's #collaborate, #innovate, and serve #EveryoneEverywhere Together, we create #HealthForAll. 📅 Date: 8-10 October 2024 📍 Location: CPHI Milan, #FieraMilano-Italy; Booth: 24A1, Hall 24, Zone Integrated Pharma #Hetero #CPHI2024 #Pharma #GlobalHealth #AffordableMedicines #ForEveryoneEverywhere #CPHI